Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trial.
Cardiovascular diabetology（2023）
摘要
EudraCT number 2015-004571-73.
更多查看译文
关键词
Empagliflozin, Insulin resistance, Myocardial infarction, Dysglycaemia, Cardiac magnetic resonance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要